Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transcription initiation factor TFIID subunit 5 (TAF5) is a core component of the TFIID complex, which is essential for the initiation of transcription by RNA polymerase II[1][6]. TFIID includes the TATA-box-binding protein (TBP) and multiple TBP-associated factors (TAFs), with TAF5 acting as a structural and functional subunit involved in the formation of nucleosome-like structures within TFIID[1][2]. TAF5 mediates protein–protein interactions within the TFIID complex, contributes to promoter recognition, and is involved in the assembly of the pre-initiation complex necessary for accurate transcription initiation[1][2][6]. The TFIID complex, with TAF5, functions broadly in gene expression and is implicated in the cellular response to various activators and repressors[2]. While genetic variations in TAF5 have been associated with certain cancers such as prostate adenocarcinoma and medulloblastoma, TAF5 itself is not a typical drug target and there are no known therapeutic agents that selectively modulate its activity[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transcription initiation factor TFIID subunit 5 (TAF5).